永安药业
(002365)
| 流通市值：17.66亿 | | | 总市值：21.31亿 |
| 流通股本：2.44亿 | | | 总股本：2.95亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 326,171,803.22 | 275,995,419.71 | 267,326,903.55 | 204,759,330.06 |
| 应收票据及应收账款 | 171,531,494.6 | 168,200,622.52 | 190,397,971.04 | 197,320,014.63 |
| 其中：应收票据 | 6,058,239.21 | 14,924,134.88 | 25,155,062.05 | 14,042,620.85 |
| 应收账款 | 165,473,255.39 | 153,276,487.64 | 165,242,908.99 | 183,277,393.78 |
| 应收款项融资 | - | 12,343,096.24 | 9,844,118.66 | 4,723,564.4 |
| 预付款项 | 8,795,929.39 | 22,537,064.84 | 8,548,909.72 | 8,699,688.77 |
| 其他应收款合计 | 6,054,005.66 | 6,001,591.68 | 6,941,811.12 | 8,688,273.42 |
| 其他应收款 | - | - | 6,941,811.12 | - |
| 存货 | 69,895,984.49 | 81,976,665.93 | 81,466,882.3 | 156,762,107.37 |
| 其他流动资产 | 1,047,925.75 | 1,302,635.47 | 934,460.42 | 6,593,334.32 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,213,596,306.81 | 1,211,376,305.82 | 1,212,693,798.83 | 1,207,100,328.19 |
| 非流动资产: | | | | |
| 长期股权投资 | 68,300,352.29 | 113,376,903.08 | 112,255,276.49 | 80,112,364.89 |
| 固定资产 | 927,635,265.65 | 975,302,347.4 | 1,008,349,269.22 | 941,389,670.86 |
| 在建工程 | 26,118,014.36 | 18,918,822.24 | 12,260,533.05 | 94,970,203.47 |
| 无形资产 | 82,393,203.12 | 83,235,238.59 | 84,096,321.03 | 83,638,363.49 |
| 商誉 | 517,416.38 | 8,766,208.59 | 8,766,208.59 | 8,766,208.59 |
| 递延所得税资产 | 11,258,628.03 | 9,122,147.43 | 8,736,334.39 | 10,385,110.19 |
| 其他非流动资产 | 17,318,907.02 | 5,199,502.8 | 6,295,760.4 | 5,902,827.23 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,133,541,786.85 | 1,213,921,170.13 | 1,240,759,703.17 | 1,225,164,748.72 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,347,138,093.66 | 2,425,297,475.95 | 2,453,453,502 | 2,432,265,076.91 |
| 流动负债: | | | | |
| 短期借款 | 10,014,861.11 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 160,650,811.69 | 153,547,512.42 | 141,121,936.68 | 196,416,840.18 |
| 其中：应付票据 | 31,900,000 | 30,200,000 | 13,000,000 | - |
| 应付账款 | 128,750,811.69 | 123,347,512.42 | 128,121,936.68 | 196,416,840.18 |
| 合同负债 | 15,588,007.55 | 19,148,268.96 | 17,825,591.74 | 18,189,380.46 |
| 应付职工薪酬 | 37,729,276.25 | 35,571,262.15 | 36,617,255.66 | 30,039,417.19 |
| 应交税费 | 10,239,477.48 | 18,718,620.77 | 10,370,831.81 | 3,631,641.06 |
| 其他应付款合计 | 16,079,227.23 | 11,692,958.66 | 41,860,348.67 | 7,124,316.35 |
| 应付股利 | - | - | 29,468,250 | - |
| 其他应付款 | - | - | 12,392,098.67 | - |
| 其他流动负债 | 6,953,984.12 | 14,534,953.35 | 23,453,335.87 | 13,022,015.95 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 257,255,645.43 | 263,213,576.31 | 281,249,300.43 | 278,423,611.19 |
| 非流动负债: | | | | |
| 递延收益 | 8,500,765.16 | 9,161,050.27 | 9,697,259.89 | 10,448,297.45 |
| 递延所得税负债 | 33,091,243.89 | 34,199,297.89 | 23,847,415.21 | 25,321,808.27 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 41,592,009.05 | 43,360,348.16 | 33,544,675.1 | 35,770,105.72 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 298,847,654.48 | 306,573,924.47 | 314,793,975.53 | 314,193,716.91 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 712,920,308.95 | 712,777,893.48 | 712,777,893.48 | 712,777,893.48 |
| 其他综合收益 | 4,271,652.27 | 6,475,858.35 | 6,768,281.82 | 2,466,915.47 |
| 专项储备 | 18,617,340.5 | 16,976,461.49 | 15,146,726.93 | 13,199,012 |
| 盈余公积 | 140,732,457.83 | 140,732,457.83 | 140,732,457.83 | 140,732,457.83 |
| 未分配利润 | 812,688,884.17 | 871,429,068.58 | 881,127,772.38 | 869,452,768.45 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,983,913,143.72 | 2,043,074,239.73 | 2,051,235,632.44 | 2,033,311,547.23 |
| 少数股东权益 | 64,377,295.46 | 75,649,311.75 | 87,423,894.03 | 84,759,812.77 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,048,290,439.18 | 2,118,723,551.48 | 2,138,659,526.47 | 2,118,071,360 |
| 负债和股东权益合计 | 2,347,138,093.66 | 2,425,297,475.95 | 2,453,453,502 | 2,432,265,076.91 |
| 公告日期 | 2024-04-19 | 2023-10-27 | 2023-08-24 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |